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Globally, the past few decades have witnessed a major rise in 
non-communicable diseases (NCDs) due to the growing ageing 
population, increasingly unhealthy lifestyles, and rapid unplanned 
urbanisation.[1,2] At the same time, chronic multimorbidity (also 
referred to as NCD comorbidities), defined in the context of this 
article as the co-occurrence of two or more NCDs,[3] is also increasing 
to an unprecedented extent.[4,5] The prevalence of multimorbidity in 
low- to middle-income countries (LMICs) is increasing rapidly. [6,7] 
People living with NCD multimorbidity have a high healthcare 
utilisation rate[8-10] and high rates of hospitalisation. [11,12] A study in the 
USA reported that as many as 65% of hospital medical experiences 
were associated with NCD multimorbidity.[13] Furthermore, an 
intersection of NCDs and the Sustainable Development Goals 
(SDGs) has recently been recognised in policy efforts towards and 
discourses on the achievement of the SDGs.[1] This is attributed 
to the fact that the growing burden of NCDs is likely to retard 
socioeconomic development and growth and overall attainment 
of the SDGs. Tackling the high burden of NCDs in the course of 
achieving the SDGs will therefore require transformative change 
across the health system to tackle the growing burden of NCD 
multimorbidity. Such transformative change must include initiatives 
to gather adequate and reliable NCD data, monitor and treat NCDs, 
and enhance policy coherence by addressing the challenges presented 
by high levels of comorbidities.
Despite the growing body of research on the multimorbidity 
burden from NCDs, international literature on multimorbidity is still 
insufficient, and existing data on multimorbidity reflect situations in 
high-income countries.[14] A key limitation of existing information 
on multimorbidity is that evidence on the pattern, prevalence, 
awareness and treatment of people with NCD multimorbidity is 
inadequate. In the context of South Africa (SA), although studies 
have advanced understanding of the rising burden of NCDs,[15,16] 
there is a paucity of information on the prevalence, awareness and 
treatment of multimorbidity. Knowledge of the underlying risk 
factors for the growing burden of NCD-related multimorbidity in this 
setting is also sparse. A recent study in SA reported a 4% prevalence 
of multimorbidity among adult populations, with the majority 
(70%) of those who were affected being women,[17] highlighting the 
potential gender dimension of this problem. Owing to the limited 
information on NCD multimorbidity in SA, there is little well-
established contextual evidence to inform current policy decisions to 
prevent and control its rising burden.
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Background. The prevalence of chronic non-communicable disease (NCD) comorbidity in low- to middle-income countries is increasing, 
yet evidence on the pattern, prevalence, awareness and treatment of NCD comorbidity is inadequate.
Objectives. To investigate the prevalence, awareness, treatment and control of comorbid hypertension and diabetes, and the underlying risk 
factors in Mpumza, KwaZulu-Natal Province, South Africa (SA).
Methods. Data were gathered by the SA Human Sciences Research Council from 587 participants in KwaZulu-Natal in 2015. Percentages 
were used to describe all the variables. Cross-tabulations and χ2 tests were used to describe variations in the prevalences of hypertension, 
diabetes and comorbidities according to sociodemographic and socioeconomic variables and lifestyle risk factors.
Results. Approximately a third of the participants had hypertension (32%) and 9% had diabetes. The prevalence of comorbid hypertension 
and diabetes was 6%, and this was significantly higher among women, the aged, the obese, and the formerly married compared with their 
counterparts. Comorbidity awareness was high (86%). Although most of the participants with comorbidities were being treated with lifestyle 
changes, insulin and antihypertensive medication (74%), control of comorbidities was low (13%).
Conclusion. The study reported a higher burden of comorbid hypertension and diabetes among vulnerable populations in Mpumza, SA, 
particularly women, the obese, and those with a low level of education. In addition, control of comorbidities was low. Developing appropriate 
interventions to improve control of comorbidities can reduce the risk of macrovascular and microvascular diseases in this population.
S Afr Med J 2021;111(2):149-158. https://doi.org/10.7196/SAMJ.2021.v111i2.14744
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Objectives
In light of the above, the objective of this study was to investigate 
the prevalence, awareness and control of patterns of comorbid 
hypertension and diabetes and the underlying risk factors in 
KwaZulu-Natal (KZN) Province, SA. Various studies have reported 
evidence of the burden of hypertension and diabetes in KZN.[18-20] 
Although diabetes and hypertension are the most common NCDs 
(40 - 60%),[21,22] the extent of their coexistence in KZN is unknown. 
While findings from the present study will help bridge the knowledge 
gap on NCD multimorbidity in SA, and by extension in many 
LMICs, they may also be relevant to inform the development of 
health policies to ameliorate the current multimorbidity burden and 




The data for this study were gathered in KZN. The project was 
conducted in rural and periurban communities in the province 
between January and June 2015, by the SA Human Sciences Research 
Council (HSRC).[23] The objective of the project was to understand 
the complexity, severity and prevalence of NCDs in a community 
with high HIV incidence and prevalence (Mpumza, home to ~50 000 
people). The project was a follow-up of a previous HIV home-based 
counselling and testing (HBCT) study conducted in November 2011 
and June 2012. The HIV data were not made available. The NCD data 
were anonymised before they were made available online. Informed 
consent was provided by each participant during the data collection.
In 2011/2012, a sample of 545 Mpumza households were randomly 
selected. Adults aged ≥18 years were invited to participate in the 
study. All the participants who were enrolled during the HBCT study 
in 2011/2012 and were present in 2015 were invited to participate 
in the follow-up study. Respondents for this study were all the 
587 participants whose data were made available by the HSRC.
Measurements
Hypertension prevalence, awareness, treatment and control
Consenting study participants had their blood pressure measured in 
accordance with the American Heart Association recommendations 
using Omron HBP‐1300‐E devices (Omron Global, Japan). Three 
blood pressure readings were taken at 10-minute resting intervals. 
The last two measurements were used in the study. Hypertension 
was defined as an average systolic blood pressure (SBP) ≥140 mmHg 
and/or an average diastolic blood pressure (DBP) ≥90 mmHg,[24] 
or self-report of having been diagnosed with hypertension by a 
medical professional.[24,25] Among participants who were classified as 
hypertensive, hypertension awareness was defined as self-report of 
previous diagnosis by a health professional. Hypertension treatment 
was investigated among participants who self-reported that they 
were living with hypertension. Hypertension treatment was defined 
as use of an antihypertensive in the past 2 weeks and categorised as 
1 (treatment of hypertension) or 0 (no treatment of hypertension). 
Hypertension control was checked among participants who were on 
treatment. Hypertension control was defined as an average SBP <140 
mmHg and/or an average DBP <90 mmHg.
Diabetes prevalence, awareness, treatment and control
The careET‐202 EasyTouch GC device (Roche Diabetes Care South 
Africa (Pty) Ltd.) and test strips were used to measure random plasma 
glucose. A push-button lancet safety needle was used to draw blood 
from the finger. Participants were classified as having diabetes if their 
plasma blood glucose level was ≥11 mmol/L or they self-reported 
prior diagnosis of diabetes by a medical professional. [26] Among those 
who had diabetes, diabetes awareness was defined as self-report of 
previous diagnosis by a health professional. The American Diabetes 
Association and the European Association for the Study of Diabetes 
have recommended that a combination of pharmacological treatment 
and lifestyle changes is essential for the management of type 2 
diabetes.[26] Diabetes treatment was defined as taking insulin or other 
blood sugar-lowering medication in the past 2 weeks and following 
a special diet, exercise regimen or weight control programme. If 
a respondent said yes to both the pharmacological and lifestyle 
diabetes treatment questions, they were classified as 1 (treatment of 
diabetes); those who responded no were classified as 0 (no treatment 
of diabetes). Participants living with diabetes with a blood glucose 
level <7.8 mmol/L were considered to be controlled as determined by 
the International Diabetes Federation guideline.[27]
Comorbidities prevalence, awareness, treatment and control
The outcome variable for the present study was comorbid hypertension 
and diabetes. We were interested in the prevalence, awareness, 
treatment and control of these comorbid conditions. We defined 
comorbidities as the coexistence of hypertension and diabetes.[28] 
Patients were categorised as 0 (no condition); 1 (single condition, for 
individuals with either hypertension or diabetes) or 2 (comorbidities, 
for participants with both hypertension and diabetes). Among 
participants living with comorbidities, awareness was defined as self-
reported diagnosis of both hypertension and diabetes. Comorbidities 
awareness was categorised as 0 (no awareness, if the participant 
was unaware of living with both hypertension and diabetes) and 1 
(aware, if the participant was aware of living with both diabetes and 
hypertension). Using diabetes and hypertension treatment, treatment 
of comorbidities was measured. The sample size was very small at this 
stage, so a variable was created based on the various forms of treatment 
the participants reported. These were 0 (none), 1 (lifestyle changes, 
insulin and antihypertensive), 2 (antihypertensive), 3 (insulin and 
antihypertensive), 4 (antihypertensive and lifestyle changes), and 5 
(lifestyle changes and insulin). Control of comorbidities was defined 
as 0 (none controlled), 1 (comorbidities controlled, for participants 
who had both hypertension and diabetes controlled), 2 (diabetes 
controlled) and 3 (hypertension controlled).
Independent variables
Sociodemographic data used included age (15 - 25, 26 - 35, 36 - 45, 
46 - 55 and ≥55 years) and sex (male, female). In addition, marital 
status was defined as never married, currently married and formerly 
married. Religious affiliation was defined as none, Christian and 
traditional. Socioeconomic data included level of education (none, 
primary, secondary, tertiary) and wealth quintiles (poorest, poor, 
middle, richer and richest). Principal component analysis was 
used to create the wealth index. The household assets used were 
electricity, motor vehicle, fridge, microwave, washing machine, 
landline, cell phone, radio, video machine, DSTV, computer, internet 
and television. The wealth index was equally divided into five groups 
to create wealth quintiles following the Demographic and Health 
Survey methodology.[29] The quintiles were poorest, poor, middle, 
richer and richest.
The lifestyle risk factors included in the analysis were substance 
use (alcohol and smoking), fruit and vegetable intake, self-rated 
health, and body mass index. Participants who had never consumed 
alcohol were classified as non-drinkers, those who had consumed 
alcohol but not in the past 30 days were classified as occasional 
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drinkers, and participants who had consumed alcohol in the past 
30 days were classified as regular drinkers. Participants were asked if 
they had ever smoked. Those who said yes were classified as smokers. 
Participants were asked to indicate the number of servings of fruits 
and vegetables they consumed daily. The responses were categorised 
into ≤1 servings daily, 2 - 3 servings daily, 4 - 5 servings daily and 
>5 servings daily. Body mass index (BMI) was measured using weight 
(kg) and height (cm) information collected during the survey, and 
categorised as underweight (<18.5 kg/m2), normal weight (18.5 - 
24.9 kg/m2), overweight (25 - 29.9 kg/m2) and obese (≥30 kg/m2).[30]
Statistical analyses
Percentages were used to describe all the variables. Cross-tabulations 
and χ2 tests were used to describe the variations in prevalence 
of hypertension, diabetes and comorbidities according to the 
sociodemographic and socioeconomic variables, and lifestyle risk 
factors. Owing to the small numbers for some of the cells, we could 
not fit multivariate models for the prevalence, awareness, treatment 
and control of hypertension, diabetes and comorbidities. For the 
same reason, control of comorbidities was only examined by type of 
treatment.
Ethical considerations
The HSRC was granted ethical clearance for data collection by both 
the HSRC Ethics Committee (ref. no. 1/26/05/11) and the University 
of Washington Institutional Review Board (ref. no. 48733). Only 
individuals who consented were enrolled in the survey.
Results
Background characteristics
A total of 587 participants were enrolled. Approximately two-thirds 
were female (69%) (Table 1). Ages ranged from 19 to 94 years (mean 
(standard deviation) 43.2 (17.2) years). Approximately a third had 
attained secondary school and a third high school levels of education 
(32% and 33%, respectively). More than half of the participants 
had never married (67%), and the majority were Christians (76%). 
Approximately two-thirds of the participants were in the poorest, 
poor and middle wealth quintile categories.
Seventeen percent of the participants were smokers, and close to 
half were regular drinkers (45%). Fruit and vegetable intake was low, 
<4% of the participants consuming 4 - 5 servings daily (2% and 3%, 
respectively). About 8% more men than women rated themselves as 
having very good health (38% v. 30%). With regard to BMI, more 
than two-fifths of the participants (46%) were obese. A higher 
proportion of women were obese compared with men (60% v. 16%).
Distribution of the prevalence, awareness, treatment 
and control of hypertension according to background 
characteristics
Table 2 shows the prevalence, awareness, treatment and control 
of hypertension according to background characteristics. 
Approximately a third of the sample had hypertension (32%). The 
prevalence of hypertension was twice as high among women than 
among men (p=0.00), and increased significantly with age and 
marital status. The prevalence of hypertension was also higher 
among those who rated their health as moderate (53%), bad (67%) 
and very bad (83%) than among those who rated it as good or very 
good. BMI was associated with hypertension in this sample. A 
higher proportion of subjects who were overweight and obese had 
hypertension (30% and 45%, respectively) compared with those 
who were of normal weight (12%).
Of respondents living with hypertension, ~82% were aware of their 
status. Religion was the only significant variable that predicted 
awareness of hypertension status (p=0.022); ~86% of participants 
who self-identified as Christian and traditionalist were aware of their 
hypertension status, compared with 63% of those with no religion.
Although ~82% of the sample were aware of their hypertension 
status, only 73% were on treatment. Hypertension treatment was 
significantly associated with age, level of education and smoking 
status. A higher proportion of participants aged 45 - 54 years (71%) 
were on treatment compared with those aged 15 - 24 (33%) (p=0.001). 
The proportion of participants on treatment was lower among those 
with higher education (50%) compared with those with no education 
(87%) (p=0.017). More participants who did not smoke (76%) were 
on treatment compared with those who smoked (53%) (p=0.036).
Hypertension control was generally low in this sample. 
Approximately a third of the participants who were on treatment 
had their blood pressure controlled (37%). Hypertension control was 
lower among those who were overweight and obese compared with 
those who were of normal weight (p=0.041). With regard to wealth 
quintiles, a little above half of those in the poor (54%) and richer 
group (53%) had their blood pressure controlled (p=0.029).
Distribution of the prevalence, awareness, treatment 
and control of diabetes according to background 
characteristics
The prevalence of diabetes in this sample was 9% (Table 3). Diabetes 
prevalence was significantly associated with sex, age, level of 
education, marital status, smoking status, self-rated health and BMI. 
Diabetes prevalence was higher among females compared with males, 
and increased with age. Approximately two out of five participants 
aged ≥55 years had diabetes (20%) compared with those aged 15 - 
24  years (3%) (p=0.000). A third of participants who had formerly 
been married had diabetes (32%) compared with 5% of the never-
married (p=0.000). The prevalence of diabetes was higher among 
those who reported that their health was bad (23%) compared with 
those who said it was very good (3%) (p=0.000). Approximately 14% 
of those were obese were living with diabetes (p=0.000).
Approximately four out of five people living with diabetes were 
aware of their status (79%). The variables that significantly predicted 
diabetes awareness were age (p=0.000) and marital status (p=0.000). 
Individuals in the older age categories tended to be more aware of 
their status compared with those in the younger age groups. For 
example, the majority of participants aged 45 - 54 years (80%) and 
≥55 years (91%) were aware of their status, while for those aged 25 - 
34 years the figure was 50%.
All the men were on treatment, while ~16% of women were not on 
treatment. Although not significant, the proportion on treatment was 
higher among respondents aged ≥55 (93%) and 45 - 54 years (75%) 
compared with those aged 25 - 34 years (50%). Among participants 
living with diabetes, all of those with higher education (100%) were 
on treatment compared with only two-thirds (67%) of those with 
primary education (p=0.003). All participants who were formerly 
married were on treatment (100%) compared with two-thirds of 
those who had never married (62%) (p=0.005). Only one out of five 
participants had their glucose controlled (23%). Diabetes control was 
not significantly related to any of the predicting variables.
Distribution of the prevalence, awareness and treatment 
of comorbidities according to background characteristics
Table 4 illustrates the prevalence of comorbid hypertension and 
diabetes according to sociodemographic, socioeconomic and lifestyle 
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Table 1. Characteristics of respondents
Variable Male (n=183), % Female (n=404), % Total (N=587), %
Age (years)
15 - 24 16.9 9.4 11.7
25 - 34 28.4 27.0 27.4
35 - 44 18.0 21.0 20.1
45 - 54 14.2 12.4 12.9
≥55 22.4 30.2 27.8
Level of education
No education 10.4 15.1 13.6
Primary 19.7 18.1 18.6
Secondary school 32.2 32.2 32.2
High school 34.4 32.9 33.4
Tertiary 3.3 1.7 2.2
Marital status
Never married 68.3 66.3 67.0
Currently married 28.4 23.5 25.0
Formerly married 3.3 10.1 8.0
Religion
None 37.2 11.6 19.6
Christian 58.5 84.2 76.2
Traditional 4.4 4.2 4.3
Wealth quintiles
Poorest 23.5 19.5 20.8
Poor 22.9 22.8 22.8
Middle 17.5 26.7 23.8
Richer 18.0 13.4 14.8
Richest 18.0 17.6 17.7
Smoking status
Smoker 40.4 6.0 17.0
Non-smoker 59.6 94.0 83.0
Alcohol use 
None 46.4 49.7 48.7
Occasional 14.7 2.7 6.5
Regular 38.8 47.5 44.8
Fruit intake (servings/day)
≤1 65.6 55.2 58.4
2 - 3 32.2 42.1 39.0
4 - 5 1.6 2.2 2.0
>5 0.6 0.5 0.6
Vegetable intake (servings/day)
≤1 34.3 31.9 32.7
2 - 3 62.3 64.6 63.9
4 - 5 3.4 3.5 3.4
Self-rated health 
Very good 37.7 30.2 32.5
Good 38.2 33.4 34.9
Moderate 19.1 29.7 26.4
Bad 4.9 5.2 5.1
Very bad 0 1.5 1.0
BMI
Underweight 3.8 1.5 2.2
Normal weight 51.9 14.6 26.2
Overweight 28.4 23.8 25.2
Obese 15.8 60.1 46.3
Total 100 100 100
BMI = body mass index.
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Table 2. Prevalence, awareness, treatment and control of hypertension according to background characteristics
Variable Prevalence (N=587), % Awareness (n=188), % Treatment (n=154), % Control (n=112), %
Sex
Male 19.1* 71.4 80.0 30.0
Female 37.9 84.3 71.3 38.0
Age (years)
15 - 24 4.3* 100 33.3 0
25 - 34 9.9 75.0 33.3 20.0
35 - 44 22.0 76.9 55.0 60.0
45 - 54 36.8 75.0 71.4 33.3
≥55 70.6 85.2 82.7 35.8
Level of education
No education 56.2* 84.4 86.8 48.5
Primary 48.6 88.7 80.8 34.2
Secondary school 30.7 77.6 62.2 28.6
High school 14.8 75.9 54.5 33.3
Tertiary 23.1 66.7 50.0 0
Marital status
Never married 21.4 80.9 63.2 40.5
Currently married 49.7 80.8 81.4 34.7
Formerly married 66.0 87.1 77.8 33.3
Religion
None 23.5 63.0* 76.5 69.2
Christian 28.0 85.7 83.3 40.0
Traditional 34.5 85.1 71.8 31.9
Wealth index
Poorest 37.7 84.8 71.8 35.7*
Poor 32.1 83.7 72.2 53.8
Middle 27.9 84.6 78.8 16.0
Richer 31.0 77.8 76.2 52.9
Richest 31.7 75.8 64.0 25.0
Smoking status
Smoker 22.0 86.4 52.6 30.0
Non-smoker 34.1 79.2 75.6 37.2
Alcohol use
None 32.9 84.0 77.2 38.3
Occasional 28.9 72.7 62.5 20.0
Regular 31.6 80.7 68.7 36.2
Fruit intake (servings/day)
≤1 32.1 80.9 79.8 38.0
2 - 3 32.3 82.4 62.3 31.6
4 - 5 25.0 100 66.7 50.0
>5 33.3 100 100 100
Vegetable intake (servings/day)
≤1 26.6 86.3 79.5 37.1
2 - 3 34.3 80.9 71.7 36.8
4 - 5 30.0 66.7 25 0
Self-rated health 
Very good 16.2 80.6 72 38.9
Good 24.4 74.0 64.7 20.8
Moderate 52.9 84.2 79.7 40.0
Bad 66.7 90.0 66.7 50.0
Very bad 83.3 100 60 33.3
BMI
Underweight 15.4 100 100 100*
Normal weight 12.3 68.4 61.5 0.0
Overweight 30.4 84.4 63.2 40.0
Obese 44.9 82.8 77.2 37.7
Total 32.03 81.9 72.7 36.6
BMI = body mass index.
*Significant (p<0.05).
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Table 3. Distribution of diabetes prevalence, awareness, treatment and control according to background characteristics
Variable Prevalence (N=587), % Awareness (n=52), % Treatment (n=41), % Control (n=35), %
Sex
Male 2.7* 60.0* 100 0
Female 11.6 80.8 84.2 25.0
Age (years)
15 - 24 2.9* 0 0 0
25 - 34 2.5 50.0 50.0 0
35 - 44 6.8 62.5 60.0 33.3
45 - 54 6.6 80.0 75.0 33.3
≥55 20.2 90.9 93.3 78.6
Level of education
No education 16.2* 100 100 30.7
Primary 12.8 85.7 66.7 25.0
Secondary school 5.8 81.8 77.8 14.3
High school 6.1 50.0 100 16.7
Tertiary 15.4 50.0 100 0
Marital status
Never married 5.1* 65.0* 61.5 25.0
Currently married 11.6 82.3 92.9 23.1
Formerly married 31.9 93.3 100 21.4
Religion
None 5.2 83.3 80.0 50.0
Christian 8.0 100 100 50.0
Traditional 9.8 77.3 85.3 17.2
Wealth index
Poorest 9.0 81.8 100 22.2
Poor 11.2 86.7 69.2 22.2
Middle 8.6 83.3 80.0 25.0
Richer 4.6 75.0 100 33.3
Richest 9.6 60.0 100 16.7
Smoking status
Smoker 2.0 100.0 50.0 0
Non-smoker 10.3 78.0 87.2 23.5
Alcohol use
None 10.5 86.7 84.6 0
Occasional 2.6 0 0 22.7
Regular 8.0 71.4 86.7 23.1
Fruit intake (servings/day)
≤1 9.3 75.0 79.2 21.0
2 - 3 7.9 83.3 93.3 28.6
4 - 5 8.3 100 100 0
>5 33.3 100 100 0
Vegetable intake (servings/day)
≤1 9.4 88.9 81.2 23.1
2 - 3 8.8 71.9 86.9 25.0
4 - 5 10.0 100 100 0
Self-rated health 
Very good 3.1* 66.7 100 0
Good 6.3 61.5 87.5 14.3
Moderate 16.1 88.0 81.8 27.8
Bad 23.3 85.7 83.3 20.0
Very bad 16.7 100 100 100
BMI
Underweight 0* 0 0 0
Normal weight 1.9 100 66.7 0
Overweight 6.8 80.0 87.5 14.3
Obese 14.3 76.9 86.7 26.9
Total 8.9 78.9 85.4 22.9
BMI = body mass index.
*Significant (p<0.05).
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Table 4. Distribution of comorbidities prevalence
Variable None, % Single condition, % Comorbidities, %
Sex
Male 79.8* 18.6 1.6
Female 58.7 33.2 8.2
Age (years)
15 - 24 92.7* 7.2 0
25 - 34 87.6 12.4 0
35 - 44 73.7 23.7 2.5
45 - 54 60.5 35.5 3.9
≥55 27.6 54.0 18.4
Level of education
No education 41.2 45.0 13.7
Primary 49.5 39.4 11.0
Secondary school 68.2 27.0 4.8
High school 80.6 17.9 1.5
Tertiary 69.2 23.1 7.7
Marital status
Never married 75.8* 21.9 2.3
Currently married 48.3 42.2 9.5
Formerly married 29.8 42.6 27.7
Religion
None 74.8 21.7 3.5
Christian 72.0 20.0 8.0
Traditional 62.4 30.9 6.7
Wealth index
Poorest 61.5 30.3 8.2
Poor 64.2 28.4 7.5
Middle 67.9 27.9 4.3
Richer 67.0 26.4 4.6
Richest 64.2 29.8 5.8
Smoking status
Smoker 77.0 22.0 1.0
Non-smoker 62.8 23.0 7.2
Alcohol use
None 64.3 28.0 7.7
Occasional 71.0 26.3 2.6
Regular 65.4 29.7 4.9
Fruit intake (servings/day)
≤1 64.1 30.3 5.5
2 - 3 66.4 27.1 6.6
4 - 5 75.0 16.7 8.3
>5 66.7 0 33.3
Vegetable intake (servings/day)
≤1 68.7 26.6 4.7
2 - 3 63.2 30.1 6.7
4 - 5 70.0 30.0 10.0
Self-rated health 
Very good 82.2 16.2 1.6
Good 73.2 22.9 3.9
Moderate 42.6 45.8 11.6
Bad 33.3 43.3 23.3
Very bad 0 100 0
BMI
Underweight 84.6 15.4 0
Normal weight 87.0 11.7 1.3
Overweight 68.2 26.3 5.4
Obese 50.4 40.1 9.5
Total 65.2 28.6 6.1
BMI = body mass index.
*Significant (p<0.05).
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factors. The overall prevalence of comorbidities was 6%. A higher 
proportion of women (8%) had comorbidities compared with men (2%) 
(p=0.000). The prevalence of comorbidities increased with age. The age 
group >55 years had a significantly higher proportion of participants 
living with comorbidities (18%) than the younger age groups, and none 
of those aged 15 - 34 years had comorbid hypertension and diabetes. 
In addition, the prevalence of comorbidities among participants who 
had no education was ~14%, while those with tertiary education had 
a prevalence of ~8%. A significant association between marital status 
and comorbidities was also found. The prevalence of comorbidities was 
highest among those who had formerly been married (28%) and lowest 
among those who had never married (2%). Although the association 
was not significant, the prevalence of comorbidities was higher in poor 
households compared with richer households.
One of five participants who rated their health as bad had 
comorbidities (23%). As expected, a significant association was found 
between BMI and comorbidities. Participants who were obese recorded 
the highest prevalence of comorbidities (10%), compared with 1% of 
those of normal weight. Fruit and vegetable intake and alcohol use were 
not significantly associated with comorbidities.
Table 5 presents levels of awareness of comorbidities and the 
treatments the participants were using. The majority of the respondents 
(86%) were aware of their conditions. Most were on treatment, and 
many (74%) followed the recommended combination of lifestyle 
changes, insulin and antihypertensive medication. However, some 
of the participants did not follow the recommended treatment. 
Approximately 7% were only on pharmacological treatment with no 
lifestyle changes. Another 3% only treated their hypertension and 
diabetes, respectively. 
Control of comorbidities is shown in Table 6. A high proportion 
of the participants had uncontrolled hypertension and diabetes 
(71%). Approximately 17% of the participants who had controlled 
comorbidities were those who were using the lifestyle change, insulin 
and antihypertensive treatment regimen. All the participants who 
were not on treatment were uncontrolled.
Discussion
Hypertension prevalence, awareness, treatment and 
control
The study revealed that a third of the respondents in rural KZN were 
living with hypertension; 73% were on treatment, while more than a 
third of those treated were controlled. The prevalence was relatively 
low in this study compared with two studies on hypertension in 
SA and one comparative study in SA and Ghana. In a study of 
comorbidities in the Agincourt study site in SA, a prevalence of 63% 
was found.[31] In Wave 2 of the World Health Organization-funded 
Global Study on Ageing and Adult Health (SAGE), a hypertension 
prevalence of 43% was reported.[32] Furthermore, while we found a 
37% control rate, more recent hypertension studies in SA report much 
lower levels of control (18 - 24%).[31,32] The same pattern was observed 
for awareness and treatment. We found higher levels of awareness 
and treatment of hypertension compared with other studies. These 
differences could be explained by differences in the study population 
and perhaps the methodology. The SAGE data are primarily focused 
on the elderly population and therefore more likely to have higher 
estimates for conditions that are sensitive to ageing. Hypertension 
control is lower among the elderly for a variety of reasons, including 
limited income and having to depend on others for help. These 
reasons may challenge the drive for optimal hypertension treatment 
and subsequent control. However, our findings were consistent with 
regional-level hypertension studies where broad levels of prevalence 
were noted among different subpopulations.[33-35] Crucially, over the 
past few years, hypertension and related complications have become a 
major part of the epidemiological profile both in SA and the broader 
African region.
Diabetes prevalence, awareness, treatment and control
The study showed that 9% of the respondents in rural KZN had 
type 2 diabetes, and this is slightly lower than the national estimate 
of 9.8%.[36] Among individuals with diabetes, 79% were aware that 
they had it, and >85% of those who were aware of their condition 
were receiving treatment for it. Slightly more than one-fifth of those 
receiving treatment achieved adequate glycaemic control through 
treatment; this proportion is slightly higher than that observed in a 
study conducted in rural KZN (15.7%) describing the nature of care, 
glycaemic control and diabetes complications among patients with 
diabetes receiving treatment from a public hospital.[37]
The results clearly show that glycaemic control is a challenge in this 
population. Evidence from the KZN Department of Health showed 
Table 5. Awareness and treatment of comorbidities






No treatment 3 (9.7)
Lifestyle changes, insulin, antihypertensive 23 (74.2)
Antihypertensive 1 (3.2)
Insulin and antihypertensive 2 (6.5)
Antihypertensive and lifestyle changes 1 (3.2)
Lifestyle changes and insulin 1 (3.2)
Total 31 (100)
Table 6. Control of comorbidities according to type of treatment
Treatment 
Control, %
None controlled Comorbidities controlled Diabetes controlled Hypertension controlled
No treatment 100 - - -
Lifestyle changes, insulin, antihypertensive 69.6 17.4 - 13.0
Antihypertensive - - - 100
Insulin and antihypertensive 100 - - -
Antihypertensive and lifestyle changes 100 - - -
Lifestyle changes and insulin - - 100 -
Total 70.9 12.9 3.2 12.9
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that the number of clinic visits by diabetic patients in the province 
has increased significantly over time.[38] Coupled with this, the large 
majority of people diagnosed with diabetes are seeking medical 
care, and the number of treatment defaulters reduced significantly 
between 2006 and 2016.[38] What is unclear is why, despite these 
impressive success stories, glycaemic control remains a problem in 
the study area. Research revealed that adequate glycaemic control can 
reduce the risk of cardiovascular diseases in patients with diabetes.[39] 
Nevertheless, the relatively low glycaemic control in this population 
suggests the need for urgent interventions to minimise diabetes 
complications such as microvascular (neuropathy, nephropathy and 
retinopathy) and macrovascular (stroke and peripheral vascular 
disease) disorders.[40] Such interventions may be achieved by 
strengthening the local clinics in the province in terms of resources, 
staffing and clinician education.[41]
Furthermore, the findings showed that sociodemographic 
characteristics such as sex, age, marital status and level of education 
play important roles in diabetes prevalence and awareness, just 
as has been found in previous studies.[42,43] It will be important 
to leverage existing interventions on these sociodemographic 
characteristics in developing a policy action plan to reduce the 
burden of diabetes in KZN.
Comorbidities of diabetes and hypertension
To the best of our knowledge, this is the first community-based 
study in SA to present information about comorbid hypertension 
and diabetes prevalence, awareness, treatment and control in a rural 
population. The study showed that the prevalence of comorbid 
hypertension and diabetes was 6%, and the figure was significantly 
higher among women, individuals aged ≥55 years, and those 
who were formerly married. The co-occurrence of diabetes and 
hypertension observed in this study is higher than that reported in 
similar populations in Nepal (1.8%)[44] and India (4.1%).[45] Although 
this prevalence seems low, it deserves critical attention, as research 
has shown that comorbid diabetes and hypertension increase the risk 
of developing macrovascular and microvascular diseases.[46-48]
The findings showed that the majority of respondents with 
comorbid hypertension and diabetes were aware of their conditions 
and were treating them using lifestyle changes, insulin and 
antihypertensive medications. However, only about one-tenth 
achieved hypertension and glycaemic control. The issue of comorbid 
control is clearly a problem in this population, despite a high level 
of treatment. Plausible explanations for the low level of comorbid 
hypertension and diabetes control in this population are that the 
medications used by the respondents were ineffective, or that there 
are non-adherence issues. There are three research implications for 
this. First, in future studies it will be important to explore factors 
accounting for poor hypertension and glycaemic control in KZN 
despite treatment. Second, future studies need to explore the level 
of medication adherence among those living with comorbidities of 
hypertension and diabetes. Third, it will be of great benefit to study 
the potency of antihypertensive and diabetes medications used in 
this population.
Study limitations
This study is not without limitations. The data were collected in 2015, 
and the findings may not reflect current hypertension, diabetes and 
comorbidities experiences in KZN. However, although this dataset 
was gathered in 2015, it is the first time such an analysis has been 
conducted using this dataset. More importantly, this study can be 
used as a baseline to evaluate the effectiveness of recent interventions 
by the government to address obesity and NCDs in SA. Furthermore, 
the sample size for this study was too small to do rigorous analysis. 
As a result, multivariate analysis could not be carried out to examine 
the determinants of awareness, treatment and control of hypertension 
and diabetes comorbidities in this population. Nevertheless, the 
findings provide an important description and representation of the 
burden of hypertension and diabetes comorbidities in KZN.
Conclusions
This study examined the prevalence, awareness, treatment and 
control of comorbid hypertension and diabetes and the underlying 
risk factors in Mpumza, KZN, SA. The prevalence of comorbidities 
was 6%. Although this prevalence seems low, it was higher among 
vulnerable populations, particularly women, the obese, the poor 
and those with a low level of education. Furthermore, control of 
comorbidities was also low despite a high proportion of participants 
being on treatment. It is important to pay critical attention to this 
problem, as poor control has the potential to increase the risk of 
macrovascular and microvascular diseases and reduce gains towards 
achieving health and wellbeing, as specified by the SDGs.
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